Using revenue model with the average price-to-sale ratio of 3.35 for firms in healthcare product industry.
(reference: http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/psdata.html )
The current revenue for 2015 is $33millions, with growth over 10 percent on the basis of half-year result.
The market cap from the revenue model is about $115.5 millions, => share price about $0.69
The potential for CMP is much larger, due to massive investment into R&D and eHealth.
eHealth has already secured $10millions dollar order in China.
The initial revenue once eHealth launched, already exceeded 40millions. With improving margin and weak AUD.
If CMP can grow 10% in revenue each year. In 2020, revenue is about 64millions. => market cap of $214millions (SP of $1.2)
If CMP can grow 20% in revenue each year. In 2020, revenue is about 100millions => market cap of $335 millions.(SP of $2)
CMP deserves fair valuation
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CMP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.003(0.79%) |
Mkt cap ! $57.88M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 30.0¢ | $26.84K | 85.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 14376 | 1 |
View Market Depth
| Last trade - 15.56pm 18/10/2024 (20 minute delay) ? |
| CMP (ASX) Chart |